论文部分内容阅读
目的观察核黄素磷酸钠对放疗性口咽黏膜炎症的治疗效果。方法 82例接受首次放射治疗的头颈部恶性肿瘤患者随机分为两组:治疗组42例,放疗期间每日静滴核黄素磷酸钠10mg;对照组40例,未用核黄素磷酸钠。结果治疗组放射性口咽黏膜炎症的发生率明显低于对照组(P<0.05)。两组间骨髓抑制及肝肾功能变化差异无统计学意义。结论头颈部肿瘤患者放疗中应用核黄素磷酸钠可有效减轻口咽黏膜炎症,对骨髓抑制、肝肾功能无明显影响。
Objective To observe the therapeutic effect of riboflavin sodium phosphate on radiation-induced oropharyngeal mucosal inflammation. Methods Eighty-two patients with head and neck malignant tumor undergoing first radiotherapy were randomly divided into two groups: treatment group (n = 42), ribavarin sodium (10 mg daily) during the radiotherapy period, control group (n = 40) without riboflavin phosphate . Results The incidence of radioactive oropharyngeal mucosal inflammation in the treatment group was significantly lower than that in the control group (P <0.05). There was no significant difference in bone marrow suppression and liver and kidney function between the two groups. Conclusion Radiotherapy of head and neck cancer patients with riboflavin sodium phosphate can effectively reduce inflammation of the oropharyngeal mucosa, bone marrow suppression, liver and kidney function no significant effect.